Colgate-Palmolive (NYSE:CL) Shares Sold by Mirova

Mirova decreased its position in Colgate-Palmolive (NYSE:CL) by 7.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 69,895 shares of the company’s stock after selling 5,359 shares during the quarter. Colgate-Palmolive comprises about 0.8% of Mirova’s holdings, making the stock its 23rd largest position. Mirova’s holdings in Colgate-Palmolive were worth $5,253,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Tucker Asset Management LLC acquired a new position in Colgate-Palmolive in the 1st quarter valued at about $27,000. Register Financial Advisors LLC acquired a new position in shares of Colgate-Palmolive during the 1st quarter valued at about $30,000. Kepos Capital LP acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $40,000. Carmel Capital Partners LLC acquired a new position in shares of Colgate-Palmolive during the 1st quarter valued at about $42,000. Finally, Newbridge Financial Services Group Inc. increased its stake in shares of Colgate-Palmolive by 108.7% during the 1st quarter. Newbridge Financial Services Group Inc. now owns 578 shares of the company’s stock valued at $43,000 after acquiring an additional 301 shares during the last quarter. Institutional investors and hedge funds own 78.36% of the company’s stock.

Insider Activity at Colgate-Palmolive

In related news, insider John W. Kooyman sold 21,677 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $77.69, for a total transaction of $1,684,086.13. Following the sale, the insider now directly owns 6,384 shares of the company’s stock, valued at approximately $495,972.96. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, insider John W. Kooyman sold 21,677 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $77.69, for a total transaction of $1,684,086.13. Following the sale, the insider now directly owns 6,384 shares of the company’s stock, valued at approximately $495,972.96. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Gregory Malcolm sold 10,493 shares of the company’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $73.90, for a total value of $775,432.70. Following the sale, the vice president now directly owns 7,852 shares in the company, valued at $580,262.80. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $73.20 on Friday. The stock has a market cap of $60.51 billion, a P/E ratio of 40.67, a price-to-earnings-growth ratio of 3.13 and a beta of 0.50. The company has a current ratio of 1.17, a quick ratio of 0.73 and a debt-to-equity ratio of 28.43. The stock has a 50 day moving average of $75.42 and a 200-day moving average of $75.83. Colgate-Palmolive has a 52 week low of $67.84 and a 52 week high of $82.09.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 28th. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.75 by $0.02. The company had revenue of $4.82 billion during the quarter, compared to analysts’ expectations of $4.70 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 8.02%. The business’s revenue was up 7.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.72 EPS. On average, analysts expect that Colgate-Palmolive will post 3.17 EPS for the current fiscal year.

Wall Street Analyst Weigh In

CL has been the subject of a number of research analyst reports. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $83.00 price objective on shares of Colgate-Palmolive in a research note on Monday, July 31st. Barclays increased their target price on shares of Colgate-Palmolive from $77.00 to $81.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 1st. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Saturday, September 2nd. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Colgate-Palmolive from $88.00 to $91.00 and gave the stock a “buy” rating in a research report on Monday, July 31st. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $85.33.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.